C=VC2
Book a triage
Venture capital · Exit & liquidity intelligence
Your 2019–2021 vintage has a buyer problem, not a markup problem.
ChronoCurve ranks a healthcare venture portfolio by realizable value and by route, and reports what the preference stack actually leaves the fund at each outcome.
- Fixed fee
- One partner signature
- Credited against a platform agreement
Last round post-money$420.0MHeld at$38.0MRouteStrategic sale
Realistic strategic bid (P50)
$180.0M
Preference stack ahead of the fund
$145.2M
What the fund actually receives
$12.4M
Held at $38.0M. Receives $12.4M at a realistic bid. The waterfall, not the headline valuation, determines the distribution.
What the 2026 market is telling you
52%
of buyout-backed companies have been held four years or longer — up from 43% in 2024
16,000+
companies globally sitting in that four-plus-year backlog
6.6 yrs
average holding period across buyout-backed inventory
19%
of 2021 acquisitions sold by 2025, against a roughly 30%-by-year-four historical norm
Source: McKinsey & Company, Global Private Markets Report 2026, pp. 3, 14.